BF&M and Argus Group Holdings, both Bermudian companies offering insurance, pensions and investment services, have entered a definitive deal to merge their businesses.

The all-stock deal will see Argus amalgamate with BF&M subsidiary Eleos Health.

Argus shareholders will receive 0.251 BF&M common shares for each held, resulting in BF&M shareholders owning nearly 60% and Argus shareholders owing around 40% of the combined entity.

The deal has been unanimously approved by the two companies’ boards, which expect the merger to create a more robust and diversified insurance group.

The combined company, which will be renamed, is expected to offer enhanced business portfolios across property and casualty, life, health and pensions.

Other strategic benefits of the amalgamation include greater scale in healthcare amidst increasing costs in Bermuda and expanded geographic reach.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Financially, the merger is expected to yield a higher-quality earnings profile due to portfolio diversification.

The increased scale of the merged entity is aimed at expediting growth plans and facilitating ongoing products investment.

Awaiting regulatory and shareholder clearances, this transaction is due to close in Q4 2024.

Service to customers of both companies will remain uninterrupted post-merger, with BF&M shares continuing to trade on the Bermuda Stock Exchange, while Argus shares will be delisted.

BF&M Abigail Clifford CEO will lead the combined group as CEO, while Argus CFO and deputy CEO Peter Dunkerley will take on the role of CFO.

The board of directors will comprise six current BF&M directors and four from Argus, with Anthony Joaquin continuing as chairman.

Clifford noted: “This proposed combination would meaningfully accelerate our progress across BF&M’s three strategic pillars – growth, efficiency and service – and better position both organisations to navigate the rapidly evolving insurance landscape as one unified enterprise.

“Together, we are committed to maintaining our proud heritage as Bermudian businesses and developing innovative solutions to improve the quality of life for our island while ensuring our insureds and patients have choice and access to care.”